Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EPC
EPC logo

EPC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Edgewell Personal Care Co (EPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
22.990
1 Day change
0.22%
52 Week Range
27.460
Analysis Updated At
2026/06/12
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

EPC is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has short-term bullish momentum, but it is overbought, has no strong proprietary buy signal, and analyst sentiment is only mixed-to-neutral. I would not chase it at the current price of $21.65; the better call is to hold and wait for a clearer pullback or stronger fundamental confirmation.

Technical Analysis

The trend is constructive but extended. MACD histogram is positive and expanding, which supports upside momentum. However, RSI_6 at 88.797 signals the stock is highly overbought, making the current entry unattractive for a beginner investor. Moving averages are converging, suggesting a possible inflection area rather than a clean breakout. Price is trading above the pivot at 19.527 and near first resistance at 21.414, with the next resistance at 22.58. The stock trend model also points to negative near-term drift, with a 70% chance of -2.77% next day, -3.11% next week, and -3.16% next month. That argues against buying immediately.

Options Data

Neutral
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is slightly bearish-to-neutral on open interest, because the put-call open interest ratio near 1.0 shows balanced positioning. But the very low option volume put-call ratio of 0.14 indicates heavier call activity today, which leans bullish in the very short term. Implied volatility is elevated at 78.06, historical volatility is 60.62, and today’s option activity is much higher than the 30-day average, so traders are active. Overall, options suggest near-term speculation, not a clean long-term buy signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
8

Positive Catalysts

  • ["MACD is positive and expanding, showing current upward momentum.", "Price is above the main pivot level, indicating the stock has not broken down.", "Analyst price targets have moved slightly higher at UBS from $21 to $23.", "Options flow shows strong call-side interest today.", "Broader consumer/CPG narrative may benefit from improving sentiment around category resilience."]

Neutral/Negative Catalysts

  • ["RSI is extremely overbought, which raises the risk of near-term pullback.", "No AI Stock Picker or SwingMax buy signal is present today.", "Modelled stock trend implies negative returns over the next day, week, and month.", "Analyst sentiment is mixed, with UBS Neutral and RBC only mildly constructive.", "Hedge funds and insiders show no significant positive trading trend.", "No recent congress trading data provides no supportive political signal.", "No strong financial snapshot was available to confirm accelerating fundamentals."]

Financial Performance

Financial data was not available due to an error in the snapshot, so there is no confirmed latest-quarter revenue or earnings detail to assess. The only qualitative growth context from the news is about Mammoth Brands, not Edgewell, so it does not strengthen EPC’s own fundamental case. For EPC specifically, the provided data does not show a recent financial acceleration that would justify buying at this level.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed and mostly neutral. UBS raised its target to $23 from $21 but kept a Neutral rating, which is modestly positive but not a buy call. RBC lowered its target to $26 from $27 while keeping Outperform, citing a still-sluggish top-line environment and inflation-related risks despite some improvement from a ceasefire. Overall, Wall Street sees some upside, but the pros view is cautious rather than strongly bullish.

Wall Street analysts forecast EPC stock price to rise
5 Analyst Rating
Wall Street analysts forecast EPC stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 22.650
sliders
Low
19
Averages
23.6
High
32
Current: 22.650
sliders
Low
19
Averages
23.6
High
32
UBS
Peter Grom
Neutral
maintain
$21 -> $23
AI Analysis
2026-05-08
Reason
UBS
Peter Grom
Price Target
$21 -> $23
AI Analysis
2026-05-08
maintain
Neutral
Reason
UBS analyst Peter Grom raised the firm's price target on Edgewell Personal Care to $23 from $21 and keeps a Neutral rating on the shares.
RBC Capital
Nik Modi
Outperform
downgrade
$27 -> $26
2026-04-09
Reason
RBC Capital
Nik Modi
Price Target
$27 -> $26
2026-04-09
downgrade
Outperform
Reason
RBC Capital analyst Nik Modi lowered the firm's price target on Edgewell Personal Care to $26 from $27 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results in Home and Personal Care, Beverages, and Packaged Food categories, The March quarter should be fine, characterized by a still sluggish top-line environment, though much of the emphasis will be on forward commentary due to Middle East conflict, which has created top-line and inflationary risks, the analyst tells investors in a research note. This ceasefire announcement is a positive but the firm still expects lingering impacts and elevated commodity prices relative to prior to the conflict, RBC added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EPC
Unlock Now

People Also Watch